Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.

about

Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.

Item

http://www.wikidata.org/entity/Q47119741

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Spotlight on solithromycin in ...... nd potential place in therapy.

@en

Spotlight on solithromycin in ...... nd potential place in therapy.

@nl

type

Item

label

Spotlight on solithromycin in ...... nd potential place in therapy.

@en

Spotlight on solithromycin in ...... nd potential place in therapy.

@nl

prefLabel

Spotlight on solithromycin in ...... nd potential place in therapy.

@en

Spotlight on solithromycin in ...... nd potential place in therapy.

@nl

P1476

Spotlight on solithromycin in ...... nd potential place in therapy.

@en

P2093

Bryan J Donald

http://www.w3.org/2001/XMLSchema#string

Harmeet S Deol

http://www.w3.org/2001/XMLSchema#string

Salim Surani

http://www.w3.org/2001/XMLSchema#string

Uche J Mbadugha

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors

Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis

In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms

A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy

Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

The incidence rate and economic burden of community-acquired pneumonia in a working-age population

In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.

P304

3559-3566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/DDDT.S119545

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

G O Udeani

P5008

ScienceSource

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29263651

http://www.w3.org/2001/XMLSchema#string

P921

P932

5732564

http://www.w3.org/2001/XMLSchema#string